A research agenda for helminth diseases of humans: Diagnostics for control and elimination programmes

PLoS Neglected Tropical Diseases

Volumn 6, Issue 4, 2012, Pages

  McCarthy, James S ^a   Lustigman, Sara ^b   Yang, Guo Jing ^c   Barakat, Rashida M ^d   García, Héctor H ^e   Sripa, Banchob ^f   Willingham, Arve Lee ^g   Prichard, Roger K ^h   Basáñez, María Gloria ⁱ  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b NEW YORK BLOOD CENTER   (United States)

^c JIANGSU INSTITUTE OF PARASITIC DISEASES   (China)

^d High Institute of Public Health Egypt   (Egypt)

^e UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^f KHON KAEN UNIVERSITY   (Thailand)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

^h MCGILL UNIVERSITY   (Canada)

ⁱ IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHELMINTIC AGENT; PRAZIQUANTEL;

ANTIBODY DETECTION; ANTIGEN DETECTION; CHEMOTHERAPY; CYSTIC HYDATID DISEASE; CYSTICERCOSIS; DISEASE SEVERITY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FOOD BORNE TREMATODIASIS; HEALTH PROGRAM; HELMINTHIASIS; HUMAN; LYMPHATIC FILARIASIS; NONHUMAN; ONCHOCERCIASIS; PARASITE CONTROL; PARASITE IDENTIFICATION; POLYMERASE CHAIN REACTION; REVIEW; SCHISTOSOMIASIS; SENSITIVITY AND SPECIFICITY; SOIL TRANSMITTED HELMINTHIASIS; TAENIASIS; WORM INFECTION; DIAGNOSTIC PROCEDURE; DRUG MONITORING; INFECTION CONTROL; METHODOLOGY; PARASITOLOGY;

CLINICAL LABORATORY TECHNIQUES; COMMUNICABLE DISEASE CONTROL; DRUG MONITORING; HELMINTHIASIS; HUMANS; PARASITOLOGY;

EID: 84859006846     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001601     Document Type: Review

References (114)

1. Lustigman S, Prichard RK, Gazzinelli A, Grant WN, Boatin BA, et al. (2012) A research agenda for helminth diseases of humans: the problem of helminthiases. PLoS Negl Trop Dis 6: e1582 doi:10.1371/journal.pntd.0001582.
2. Vercruysse J, Albonico M, Behnke J, Kotze, Prichard R, et al. (2011) Is anthelmintic resistance a concern for the control of human soil-transmitted helminths? Int J Parasitol: Drugs and Drug Resistance 1: 14-27.
3. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, et al. (2007) Control of neglected tropical diseases. N Engl J Med 357: 1018-1027.
4. Levecke B, Behnke JM, Ajjampur SS, Albonico M, Ame SM, et al. (2011) A comparison of the sensitivity and fecal egg counts of the McMaster egg counting and Kato-Katz thick smear methods for soil-transmitted helminths. PLoS Negl Trop Dis 5: e1201 doi:10.1371/journal.pntd.0001201.
5. Basáñez MG, McCarthy JS, French MD, Yang GJ, Walker M, et al. (2012) A research agenda for helminth diseases of humans: modelling for control and elimination. PLoS Negl Trop Dis 6: e1548 doi:10.1371/journal.pntd.0001548.
6. Geary TG, Woo K, McCarthy JS, Mackenzie CD, Horton J, et al. (2010) Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int J Parasitol 40: 1-13.
7. Katz N, Chaves A, Pellegrino J, (1972) A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 14: 397-400.
8. Goodman D, Haji HJ, Bickle QD, Stoltzfus RJ, Tielsch JM, et al. (2007) A comparison of methods for detecting the eggs of Ascaris, Trichuris, and hookworm in infant stool, and the epidemiology of infection in Zanzibari infants. Am J Trop Med Hyg 76: 725-731.
9. Ramsan M, Montresor A, Foum A, Ameri H, Di Matteo L, et al. (1999) Independent evaluation of the Nigrosin-Eosin modification of the Kato-Katz technique. Trop Med Int Health 4: 46-49.
10. Dacombe RJ, Crampin AC, Floyd S, Randall A, Ndhlovu R, et al. (2007) Time delays between patient and laboratory selectively affect accuracy of helminth diagnosis. Trans R Soc Trop Med Hyg 101: 140-145.
11. Cringoli G, (2006) FLOTAC, a novel apparatus for a multivalent faecal egg count technique. Parassitologia 48: 381-384.
12. Knopp S, Glinz D, Rinaldi L, Mohammed KA, N'Goran EK, et al. (2009) FLOTAC: a promising technique for detecting helminth eggs in human faeces. Trans R Soc Trop Med Hyg 103: 1190-1194.
13. Utzinger J, Rinaldi L, Lohourignon LK, Rohner F, Zimmermann MB, et al. (2008) FLOTAC: a new sensitive technique for the diagnosis of hookworm infections in humans. Trans R Soc Trop Med Hyg 102: 84-90.
14. Hall A, Holland C, (2000) Geographical variation in Ascaris lumbricoides fecundity and its implications for helminth control. Parasitol Today 16: 540-544.
15. Walker M, Hall A, Anderson RM, Basáñez MG, (2009) Density-dependent effects on the weight of female Ascaris lumbricoides infections of humans and its impact on patterns of egg production. Parasit Vectors 2: 11.
16. Kotze AC, Kopp SR, (2008) The potential impact of density dependent fecundity on the use of the faecal egg count reduction test for detecting drug resistance in human hookworms. PLoS Negl Trop Dis 2: e297 doi:10.1371/journal.pntd.0000297.
17. Bennett A, Guyatt H, (2000) Reducing intestinal nematode infection: efficacy of albendazole and mebendazole. Parasitol Today 16: 71-74.
18. Keiser J, Utzinger J, (2008) Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA 299: 1937-1948.
19. Coles GC, Jackson F, Pomroy WE, Prichard RK, von Samson-Himmelstjerna G, et al. (2006) The detection of anthelmintic resistance in nematodes of veterinary importance. Vet Parasitol 136: 167-185.
20. Albonico M, Wright V, Ramsan M, Haji HJ, Taylor M, et al. (2005) Development of the egg hatch assay for detection of anthelminthic resistance in human hookworms. Int J Parasitol 35: 803-811.
21. De Clercq D, Sacko M, Behnke J, Gilbert F, Dorny P, et al. (1997) Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali. Am J Trop Med Hyg 57: 25-30.
22. Kotze AC, Coleman GT, Mai A, McCarthy JS, (2005) Field evaluation of anthelmintic drug sensitivity using in vitro egg hatch and larval motility assays with Necator americanus recovered from human clinical isolates. Int J Parasitol 35: 445-453.
23. Kotze AC, Lowe A, O'Grady J, Kopp SR, Behnke JM, (2009) Dose-response assay templates for in vitro assessment of resistance to benzimidazole and nicotinic acetylcholine receptor agonist drugs in human hookworms. Am J Trop Med Hyg 81: 163-170.
24. Prichard RK, Basáñez MG, Boatin BA, McCarthy JS, García HH, et al. (2012) A research agenda for helminth diseases of humans: intervention for control and elimination. PLoS Negl Trop Dis 6: e 1549 doi:10.1371/journal.pntd.0001549.
25. Diawara A, Drake LJ, Suswillo RR, Kihara J, Bundy DAP, et al. (2009) Assays to detect beta-tubulin codon 200 polymorphism in Trichuris trichiura and Ascaris lumbricoides. PLoS Negl Trop Dis 3: e397 doi:10.1371/journal.pntd.0000397.
26. Schwenkenbecher JM, Albonico M, Bickle Q, Kaplan RM, (2007) Characterization of beta-tubulin genes in hookworms and investigation of resistance-associated mutations using real-time PCR. Mol Biochem Parasitol 156: 167-174.
27. Albonico M, Wright V, Bickle Q, (2004) Molecular analysis of the beta-tubulin gene of human hookworms as a basis for possible benzimidazole resistance on Pemba Island. Mol Biochem Parasitol 134: 281-284.
28. Bennett AB, Anderson TJ, Barker GC, Michael E, Bundy DA, (2002) Sequence variation in the Trichuris trichiura beta-tubulin locus: implications for the development of benzimidazole resistance. Int J Parasitol 32: 1519-1528.
29. Ngoumou P, Walsh JF, Mace JM, (1994) A rapid mapping technique for the prevalence and distribution of onchocerciasis: a Cameroon case study. Ann Trop Med Parasitol 88: 463-474.
30. Duerr HP, Raddatz G, Eichner M, (2008) Diagnostic value of nodule palpation in onchocerciasis. Trans R Soc Trop Med Hyg 102: 148-154.
31. Weil GJ, Blair LS, Ewanciw DV, Malatesta PF, (1986) Use of parasite antigen detection to monitor the success of drug therapy in Dirofilaria immitis-infected dogs. J Parasitol 72: 737-740.
32. Hussein O, El Setouhy M, Ahmed ES, Kandil AM, Ramzy RM, et al. (2004) Duplex Doppler sonographic assessment of the effects of diethylcarbamazine and albendazole therapy on adult filarial worms and adjacent host tissues in Bancroftian filariasis. Am J Trop Med Hyg 71: 471-477.
33. Awadzi K, Edwards G, Opoku NO, Ardrey AE, Favager S, et al. (2004) The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus. Ann Trop Med Parasitol 98: 595-614.
34. Mand S, Marfo-Debrekyei Y, Debrah A, Buettner M, Batsa L, et al. (2005) Frequent detection of worm movements in onchocercal nodules by ultrasonography. Filaria J 4: 1.
35. Awadzi K, Attah SK, Addy ET, Opoku NO, Quartey BT, et al. (2004) Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol 98: 359-370.
36. Awadzi K, Boakye DA, Edwards G, Opoku NO, Attah SK, et al. (2004) An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol 98: 231-249.
37. Specht S, Brattig N, Buttner M, Buttner DW, (2009) Criteria for the differentiation between young and old Onchocerca volvulus filariae. Parasitol Res 105: 1531-1538.
38. Noroes J, Dreyer G, Santos A, Mendes VG, Medeiros Z, et al. (1997) Assessment of the efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo. Trans R Soc Trop Med Hyg 91: 78-81.
39. Dreyer G, Noroes J, Amaral F, Nen A, Medeiros Z, et al. (1995) Direct assessment of the adulticidal efficacy of a single dose of ivermectin in bancroftian filariasis. Trans R Soc Trop Med Hyg 89: 441-443.
40. McCarthy JS, Guinea A, Weil GJ, Ottesen EA, (1995) Clearance of circulating filarial antigen as a measure of the macrofilaricidal activity of diethylcarbamazine in Wuchereria bancrofti infection. J Infect Dis 172: 521-526.
41. Boatin BA, Richards FO Jr, (2006) Control of onchocerciasis. Adv Parasitol 61: 349-394.
42. Ozoh G, Boussinesq M, Bissek AC, Kobangue L, Kombila M, et al. (2007) Evaluation of the diethylcarbamazine patch to evaluate onchocerciasis endemicity in Central Africa. Trop Med Int Health 12: 123-129.
43. Gyapong JO, Kyelem D, Kleinschmidt I, Agbo K, Ahouandogbo F, et al. (2002) The use of spatial analysis in mapping the distribution of bancroftian filariasis in four West African countries. Ann Trop Med Parasitol 96: 695-705.
44. Onapa AW, Simonsen PE, Baehr I, Pedersen EM, (2005) Rapid assessment of the geographical distribution of lymphatic filariasis in Uganda, by screening of schoolchildren for circulating filarial antigens. Ann Trop Med Parasitol 99: 141-153.
45. Boatin BA, Basáñez MG, Prichard RK, Awadzi K, Barakat RM, et al. (2012) A research agenda for helminth diseases of humans: towards control and elimination. PLoS Negl Trop Dis 6: e1547 doi:10.1371/journal.pntd.0001547.
46. Gardon J, Gardon-Wendel N, Demanga-Ngangue, Kamgno J, Chippaux JP, et al. (1997) Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 350: 18-22.
47. Diggle P, Tawn J, Moyeed RA, (1998) Model-based geostatistics. J R Stat Soc Ser C (Appl Stat) 47: 299-350.
48. Thomson MC, Obsomer V, Dunne M, Connor SJ, Molyneux DH, (2000) Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa. Lancet 356: 1077-1078.
49. Takougang I, Meremikwu M, Wandji S, Yenshu EV, Aripko B, et al. (2002) Rapid assessment method for prevalence and intensity of Loa loa infection. Bull World Health Organ 80: 852-858.
50. Crainiceanu C, Diggle P, Rowlingson B, (2008) Bivariate binomial spatial modeling of Loa loa prevalence in tropical Africa. J Am Stat Assoc 103: 21-38.
51. WHO (1985) The control of schistosomiasis. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 728: 1-113.
52. WHO (2002) Prevention and control of schistosomiasis and soil-transmitted helminthiasis. World Health Organ Tech Rep Ser 912: i vi1-57, back cover.
53. Feldmeier H, (1993) Diagnosis in human schistosomiasis. In: Jordan P, Webbe G, Sturrock R, editors. Human schistosomiasis Oxon CAB International pp. 271-303.
54. Yu JM, de Vlas SJ, Yuan HC, Gryseels B, (1998) Variations in fecal Schistosomiasis japonicum egg counts. Am J Trop Med Hyg 59: 370-375.
55. Berhe N, Medhin G, Erko B, Smith T, Gedamu S, et al. (2004) Variations in helminth faecal egg counts in Kato-Katz thick smears and their implications in assessing infection status with Schistosoma mansoni. Acta Trop 92: 205-212.
56. Booth M, Vounatsou P, N'Goran EK, Tanner M, Utzinger J, (2003) The influence of sampling effort and the performance of the Kato-Katz technique in diagnosing Schistosoma mansoni and hookworm co-infections in rural Cote d'Ivoire. Parasitology 127: 525-531.
57. Ebrahim A, El-Morshedy H, Omer E, El-Daly S, Barakat RM, (1997) Evaluation of the Kato-Katz thick smear and formol ether sedimentation techniques for quantitative diagnosis of Schistosoma mansoni infection. Am J Trop Med Hyg 57: 706-708.
58. Kongs A, Marks G, Verle P, Van der Stuyft P, (2001) The unreliability of the Kato-Katz technique limits its usefulness for evaluating S. mansoni infections. Trop Med Int Health 6: 163-169.
59. Utzinger J, Booth M, N'Goran EK, Muller I, Tanner M, et al. (2001) Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel. Parasitology 122: 537-544.
60. Ismail M, Metwally A, Farghaly A, Bruce J, Tao LF, et al. (1996) Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Am J Trop Med Hyg 55: 214-218.
61. Gryseels B, Stelma FF, Talla I, van Dam GJ, Polman K, et al. (1994) Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal. Trop Geogr Med 46: 209-219.
62. Stelma FF, Talla I, Verle P, Niang M, Gryseels B, (1994) Morbidity due to heavy Schistosoma mansoni infections in a recently established focus in northern Senegal. Am J Trop Med Hyg 50: 575-579.
63. Doenhoff MJ, (1998) Is Schistosomicidal Chemotherapy Sub-curative? Implications for Drug Resistance. Parasitol Today 14: 434-435.
64. Botros S, Sayed H, Amer N, El-Ghannam M, Bennett JL, et al. (2005) Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt. Int J Parasitol 35: 787-791.
65. Erhart A, Dorny P, Van De N, Vien HV, Thach DC, et al. (2002) Taenia solium cysticercosis in a village in northern Viet Nam: seroprevalence study using an ELISA for detecting circulating antigen. Trans R Soc Trop Med Hyg 96: 270-272.
66. Cioli D, Botros SS, Wheatcroft-Francklow K, Mbaye A, Southgate V, et al. (2004) Determination of ED50 values for praziquantel in praziquantel-resistant and-susceptible Schistosoma mansoni isolates. Int J Parasitol 34: 979-987.
67. Melman SD, Steinauer ML, Cunningham C, Kubatko LS, Mwangi IN, et al. (2009) Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl Trop Dis 3: e504 doi:10.1371/journal.pntd.0000504.
68. Liang YS, Coles GC, Doenhoff MJ, Southgate VR, (2001) In vitro responses of praziquantel-resistant and-susceptible Schistosoma mansoni to praziquantel. Int J Parasitol 31: 1227-1235.
69. Pica-Mattoccia L, Cioli D, (2004) Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. Int J Parasitol 34: 527-533.
70. William S, Botros S, (2004) Validation of sensitivity to praziquantel using Schistosoma mansoni worm muscle tension and Ca2+-uptake as possible in vitro correlates to in vivo ED50 determination. Int J Parasitol 34: 971-977.
71. Smout MJ, Kotze AC, McCarthy JS, Loukas A, (2010) A novel high throughput assay for anthelmintic drug screening and resistance diagnosis by real-time monitoring of parasite motility. PLoS Negl Trop Dis 4: e885 doi:10.1371/journal.pntd.0000885.
72. Lamberton PH, Hogan SC, Kabatereine NB, Fenwick A, Webster JP, (2010) In vitro praziquantel test capable of detecting reduced in vivo efficacy in Schistosoma mansoni human infections. Am J Trop Med Hyg 83: 1340-1347.
73. Brooker S, Alexander N, Geiger S, Moyeed RA, Stander J, et al. (2006) Contrasting patterns in the small-scale heterogeneity of human helminth infections in urban and rural environments in Brazil. Int J Parasitol 36: 1143-1151.
74. Stothard JR, (2009) Improving control of African schistosomiasis: towards effective use of rapid diagnostic tests within an appropriate disease surveillance model. Trans R Soc Trop Med Hyg 103: 325-332.
75. De Vlas SJ, Gryseels B, Van Oortmarssen GJ, Polderman AM, Habbema JD, (1992) A model for variations in single and repeated egg counts in Schistosoma mansoni infections. Parasitology 104 (Pt 3): 451-460.
76. De Vlas SJ, Engels D, Rabello AL, Oostburg BF, Van Lieshout L, et al. (1997) Validation of a chart to estimate true Schistosoma mansoni prevalences from simple egg counts. Parasitology 114 (Pt 2): 113-121.
77. Van Lieshout L, Polderman AM, De Vlas SJ, De Caluwe P, Krijger FW, et al. (1995) Analysis of worm burden variation in human Schistosoma mansoni infections by determination of serum levels of circulating anodic antigen and circulating cathodic antigen. J Infect Dis 172: 1336-1342.
78. Polman K, De Vlas SJ, Van Lieshout L, Deelder AM, Gryseels B, (2001) Evaluation of density-dependent fecundity in human Schistosoma mansoni infections by relating egg counts to circulating antigens through Deming regression. Parasitology 122: 161-167.
79. Castillo-Chavez C, Feng Z, Xu D, (2008) A schistosomiasis model with mating structure and time delay. Math Biosci 211: 333-341.
80. Feng Z, Curtis J, Minchella DJ, (2001) The influence of drug treatment on the maintenance of schistosome genetic diversity. J Math Biol 43: 52-68.
81. Xu D, Curtis J, Feng Z, Minchella DJ, (2005) On the role of schistosome mating structure in the maintenance of drug resistant strains. Bull Math Biol 67: 1207-1226.
82. Lightowlers MW, Jensen O, Fernandez E, Iriarte JA, Woollard DJ, et al. (1999) Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep. Int J Parasitol 29: 531-534.
83. Zhang W, Zhang Z, Shi B, Li J, You H, et al. (2006) Vaccination of dogs against Echinococcus granulosus, the cause of cystic hydatid disease in humans. J Infect Dis 194: 966-974.
84. Gemmell MA, Lawson JR, Roberts MG, (1986) Population dynamics in echinococcosis and cysticercosis: biological parameters of Echinococcus granulosus in dogs and sheep. Parasitology 92 (Pt 3): 599-620.
85. Cruz M, Davis A, Dixon H, Pawlowski ZS, Proano J, (1989) Operational studies on the control of Taenia solium taeniasis/cysticercosis in Ecuador. Bull World Health Organ 67: 401-407.
86. Mahanty S, Garcia HH, (2010) Cysticercosis and neurocysticercosis as pathogens affecting the nervous system. Prog Neurobiol 91: 172-184.
87. Willingham AL 3rd, Engels D, (2006) Control of Taenia solium cysticercosis/taeniosis. Adv Parasitol 61: 509-566.
88. Jeri C, Gilman RH, Lescano AG, Mayta H, Ramirez ME, et al. (2004) Species identification after treatment for human taeniasis. Lancet 363: 949-950.
89. Gonzalez LM, Montero E, Puente S, Lopez-Velez R, Hernandez M, et al. (2002) PCR tools for the differential diagnosis of Taenia saginata and Taenia solium taeniasis/cysticercosis from different geographical locations. Diagn Microbiol Infect Dis 42: 243-249.
90. Gonzalez AE, Garcia HH, Gilman RH, Tsang VC, (2003) Control of Taenia solium. Acta Trop 87: 103-109.
91. Sarti E, Flisser A, Schantz PM, Gleizer M, Loya M, et al. (1997) Development and evaluation of a health education intervention against Taenia solium in a rural community in Mexico. Am J Trop Med Hyg 56: 127-132.
92. Garcia HH, Gilman RH, Gonzalez AE, Pacheco R, Verastegui M, et al. (1999) Human and porcine Taenia solium infection in a village in the highlands of Cusco, Peru. The Cysticercosis Working Group in Peru. Acta Trop 73: 31-36.
93. Sarti E, Schantz PM, Plancarte A, Wilson M, Gutierrez IO, et al. (1992) Prevalence and risk factors for Taenia solium taeniasis and cysticercosis in humans and pigs in a village in Morelos, Mexico. Am J Trop Med Hyg 46: 677-685.
94. Johansen MV, Sithithaworn P, Bergquist R, Utzinger J, (2010) Towards improved diagnosis of zoonotic trematode infections in Southeast Asia. Adv Parasitol 73: 171-195.
95. Dorny P, Praet N, Deckers N, Gabriel S, (2009) Emerging food-borne parasites. Vet Parasitol 163: 196-206.
96. Sithithaworn P, Tesana S, Pipitgool V, Kaewkes S, Pairojkul C, et al. (1991) Relationship between faecal egg count and worm burden of Opisthorchis viverrini in human autopsy cases. Parasitology 102 Pt 2: 277-281.
97. Adams AF, Calcagno PT, Naydenova B, (2008) Patent royalty rates: a look at recent court decisions. Available: http://www.integrityrehab.com/Patent%20Royalty%20Rates%20-%20Recent%20Court%20Decisions%20-%20Adams%204-20-08.pdf. Accessed 5 April 2012.
98. Mansfield E, O'Leary TJ, Gutman SI, (2005) Food and Drug Administration regulation of in vitro diagnostic devices. J Mol Diagn 7: 2-7.
99. More SJ, Copeman DB, (1990) A highly specific and sensitive monoclonal antibody-based ELISA for the detection of circulating antigen in bancroftian filariasis. Trop Med Parasitol 41: 403-406.
100. Weil GJ, Jain DC, Santhanam S, Malhotra A, Kumar H, et al. (1987) A monoclonal antibody-based enzyme immunoassay for detecting parasite antigenemia in bancroftian filariasis. J Infect Dis 156: 350-355.
101. Bell D, Wongsrichanalai C, Barnwell JW, (2006) Ensuring quality and access for malaria diagnosis: how can it be achieved? Nat Rev Microbiol 4: S7-S20.
102. Chappuis F, Rijal S, Soto A, Menten J, Boelaert M, (2006) A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis. BMJ 333: 723.
103. van Dam GJ, Wichers JH, Ferreira TM, Ghati D, van Amerongen A, et al. (2004) Diagnosis of schistosomiasis by reagent strip test for detection of circulating cathodic antigen. J Clin Microbiol 42: 5458-5461.
104. Moran M, Guzman J, Henderson K, Ropars A, McDonald A, et al. (2009) Neglected disease research & development: new times, new trends Sydney The George Institute for International Health Available: http://www.georgeinstitute.org.au/sites/default/files/pdfs/G-FINDER_2009_Report.pdf.
105. Murdoch T, (2008) The diagnostic path to a better world Geneva Foundation for Innovative New Diagnostics.
106. Boatin BA, Toe L, Alley ES, Nagelkerke NJ, Borsboom G, et al. (2002) Detection of Onchocerca volvulus infection in low prevalence areas: a comparison of three diagnostic methods. Parasitology 125: 545-552.
107. Lipner EM, Dembele N, Souleymane S, Alley WS, Prevots DR, et al. (2006) Field applicability of a rapid-format anti-Ov-16 antibody test for the assessment of onchocerciasis control measures in regions of endemicity. J Infect Dis 194: 216-221.
108. Chambers EW, McClintock SK, Avery MF, King JD, Bradley MH, et al. (2009) Xenomonitoring of Wuchereria bancrofti and Dirofilaria immitis infections in mosquitoes from American Samoa: trapping considerations and a comparison of polymerase chain reaction assays with dissection. Am J Trop Med Hyg 80: 774-781.
109. Lammie PJ, Weil G, Noordin R, Kaliraj P, Steel C, et al. (2004) Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis- a multicenter trial. Filaria J 3: 9.
110. Mladonicky JM, King JD, Liang JL, Chambers E, Pa'au M, et al. (2009) Assessing transmission of lymphatic filariasis using parasitologic, serologic, and entomologic tools after mass drug administration in American Samoa. Am J Trop Med Hyg 80: 769-773.
111. WHO (2008) Elimination of schistosomiasis from low-transmission areas: report of a WHO informal consultation. 18-19 August 2008; Salvador, Bahia, Brazil.
112. Zhu YC, (2005) Immunodiagnosis and its role in schistosomiasis control in China: a review. Acta Trop 96: 130-136.
113. Lier T, Johansen MV, Hjelmevoll SO, Vennervald BJ, Simonsen GS, (2008) Real-time PCR for detection of low intensity Schistosomiasis japonicum infections in a pig model. Acta Trop 105: 74-80.
114. Lier T, Simonsen GS, Wang T, Lu D, Haukland HH, et al. (2009) Real-time polymerase chain reaction for detection of low-intensity Schistosomiasis japonicum infections in China. Am J Trop Med Hyg 81: 428-432.